Pharma Focus Asia

Pharma Focus Asia Pharma Focus Asia - Magazine for Pharma Industry Leaders
https://www.linkedin.com/company/pharmafocusasia/ Ltd.. Pharma Focus Asia offers . . .

Pharma Focus Asia is a half yearly publication from Ochre Media Pvt. It is the leading pharma title in print and digital versions serving the information needs of key executives from the worldโ€™s leading pharmaceutical companies. Pharma Focus Asia covers important issues and trends shaping the future of the pharma industry across Asia and rest of the world. Dedicated, reliable and accurate coverage of the industryโ€™s progress and
Incisive analysis to help its readers make informed decisions to stay ahead of the competition. The magazine provides cutting-edge and futuristic content on the pharma industry. The issues are broadly categorized into various sections:

Strategy
Research and Development
Manufacturing
Clinical Trials
Information Technology


The one-stop pharma destination www.pharmafocusasia.com features complete content from the Pharma Focus Asia magazine. Also find the latest pharma news, press releases, pharma industry reports, interviews, trends and pharma events updated on a daily basis. The magazine is supplemented by the monthly e-Newsletter: Verticaltalk Pharma. The readership

The magazineโ€™s readership includes the top C-level executives, senior industry executives, and key decision makers from the pharma industry in charge of spending. With a special focus on Asia, Pharma Focus Asia reaches out to the key industry leaders across Asia, Europe and the Americas.

Bringing a new medicine to patients starts with getting the science right.In ๐ˆ๐ฌ๐ฌ๐ฎ๐ž ๐Ÿ”๐Ÿ ๐จ๐Ÿ ๐๐ก๐š๐ซ๐ฆ๐š ๐…๐จ๐œ๐ฎ๐ฌ ๐€๐ฌ๐ข๐š, Sneha Sitara...
02/03/2026

Bringing a new medicine to patients starts with getting the science right.

In ๐ˆ๐ฌ๐ฌ๐ฎ๐ž ๐Ÿ”๐Ÿ ๐จ๐Ÿ ๐๐ก๐š๐ซ๐ฆ๐š ๐…๐จ๐œ๐ฎ๐ฌ ๐€๐ฌ๐ข๐š, Sneha Sitaraman, Principal Scientist at Children's Hospital of Philadelphia, shares why the Discovery Stage is critical to preclinical development success.

Using advanced in silico tools, patient-derived cells, organoids, and early in vivo validation, researchers are building smarter, more predictive models that reduce late-stage failures and improve translational outcomes.

With high drug attrition rates and rising development costs, choosing the right model systems can mean the difference between clinical success and costly setbacks.

๐“๐ก๐ข๐ฌ ๐š๐ซ๐ญ๐ข๐œ๐ฅ๐ž ๐ข๐ฌ ๐ฉ๐š๐ซ๐ญ ๐จ๐Ÿ ๐จ๐ฎ๐ซ ๐ฅ๐š๐ญ๐ž๐ฌ๐ญ ๐ฆ๐š๐ ๐š๐ณ๐ข๐ง๐ž ๐ซ๐ž๐ฅ๐ž๐š๐ฌ๐žโ€”๐ˆ๐ฌ๐ฌ๐ฎ๐ž ๐Ÿ”๐Ÿ.
https://www.pharmafocusasia.com/research-development/discovery-stage-the-bedrock-for-preclinical-development

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐ญ๐ก๐ž ๐ž-๐›๐จ๐จ๐ค ๐š๐ง๐ ๐ฌ๐ญ๐š๐ฒ ๐š๐ก๐ž๐š๐ ๐ข๐ง ๐ฉ๐ก๐š๐ซ๐ฆ๐š ๐ข๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง:
https://www.pharmafocusasia.com/magazine

Regulatory delays, fragmented policies, and uneven enforcement continue to challenge Asiaโ€™s pharmaceutical growth.The la...
27/02/2026

Regulatory delays, fragmented policies, and uneven enforcement continue to challenge Asiaโ€™s pharmaceutical growth.

The latest Issue 61 of ๐๐ก๐š๐ซ๐ฆ๐š ๐…๐จ๐œ๐ฎ๐ฌ ๐€๐ฌ๐ข๐š features an in-depth article by David Braga, Bharat Rawal, and Larry Braga, examining how AI and quantum computing can modernise drug approvals, strengthen data security, and improve harmonisation across Asia-Pacific markets.

From faster NDA reviews to smarter clinical trial oversight and IP protection, this article outlines practical solutions for regulators and pharma leaders navigating complex compliance environments.

The future of pharmaceutical oversight in Asia depends on adaptive, tech-enabled systems.

๐‘๐ž๐š๐ ๐ญ๐ก๐ž ๐Ÿ๐ฎ๐ฅ๐ฅ ๐š๐ซ๐ญ๐ข๐œ๐ฅ๐ž ๐ง๐จ๐ฐ:
https://www.pharmafocusasia.com/strategy/modernising-asias-drug-regulations-ai-and-quantum-computing

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐ญ๐ก๐ž ๐ž-๐›๐จ๐จ๐ค (๐ˆ๐ฌ๐ฌ๐ฎ๐ž ๐Ÿ”๐Ÿ):
https://www.pharmafocusasia.com/magazine

A beam of light may strengthen vaccines.Studies at Massachusetts General Hospital highlight how low-power lasers can saf...
26/02/2026

A beam of light may strengthen vaccines.

Studies at Massachusetts General Hospital highlight how low-power lasers can safely enhance immune responseโ€”offering a potential alternative to traditional adjuvants.

Laser vaccine technology could support faster, scalable immunization strategies for influenza, coronavirus, and future threats.

Learn more: https://www.pharmafocusasia.com/articles/laser-vaccine-adjuvants

Clinical trial timelines are under more pressure than ever.With increasing protocol complexity and the implementation of...
25/02/2026

Clinical trial timelines are under more pressure than ever.

With increasing protocol complexity and the implementation of IE6(R3), sponsors must rethink how studies are built from the ground up.

Medidataโ€™s upcoming webinar, ๐‘๐ž๐ข๐ฆ๐š๐ ๐ข๐ง๐ข๐ง๐  ๐‚๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐’๐ญ๐ฎ๐๐ฒ ๐๐ฎ๐ข๐ฅ๐: ๐…๐š๐ฌ๐ญ๐ž๐ซ ๐š๐ง๐ ๐๐ซ๐จ๐ญ๐จ๐œ๐จ๐ฅ-๐‚๐ž๐ง๐ญ๐ซ๐ข๐œ ๐€๐ˆ-๐๐จ๐ฐ๐ž๐ซ๐ž๐ ๐€๐ฉ๐ฉ๐ซ๐จ๐š๐œ๐ก, will highlight practical strategies to:
โ€ข Transition from protocol to go-live faster
โ€ข Integrate QbD and Critical-to-Quality principles early
โ€ข Use AI-driven automation to reduce risk and optimize efficiency

๐Ÿ“… ๐Ÿ๐Ÿ’ ๐Œ๐š๐ซ๐œ๐ก ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”
๐Ÿ• ๐Ÿ:๐Ÿ‘๐ŸŽ ๐๐Œ โ€“ ๐Ÿ:๐Ÿ‘๐ŸŽ ๐๐Œ (๐†๐Œ๐“+๐Ÿ–)

๐‘๐ž๐ ๐ข๐ฌ๐ญ๐ž๐ซ ๐ญ๐จ๐๐š๐ฒ:
https://industry.pharmafocusasia.com/clientemailblast/1771923023-Medidata.html

Pharma inventory management needs precisionโ€”not guesswork.A decade-long SPC study shows:โ€ข 60% of shipments come from 33 ...
24/02/2026

Pharma inventory management needs precisionโ€”not guesswork.

A decade-long SPC study shows:
โ€ข 60% of shipments come from 33 materials
โ€ข 3 RMs drive ~60% stock weight
โ€ข 4.2% rejection rate

Data-driven stock control improves compliance, reduces waste, and supports uninterrupted production.

๐•๐ข๐ฌ๐ข๐ญ ๐จ๐ฎ๐ซ ๐ฐ๐ž๐›๐ฌ๐ข๐ญ๐ž ๐ญ๐จ ๐ฅ๐ž๐š๐ซ๐ง ๐ฆ๐จ๐ซ๐ž: https://www.pharmafocusasia.com/articles/prioritisation-of-raw-materials-in-healthcare-industry

Pharma professionals, researchers, and decision-makers: get the latest in pharma with ๐๐ก๐š๐ซ๐ฆ๐š ๐…๐จ๐œ๐ฎ๐ฌ ๐€๐ฌ๐ข๐šโ€™๐ฌ ๐ง๐ž๐ฐ๐ฌ๐ฅ๐ž๐ญ๐ญ๐ž๐ซ! St...
20/02/2026

Pharma professionals, researchers, and decision-makers: get the latest in pharma with ๐๐ก๐š๐ซ๐ฆ๐š ๐…๐จ๐œ๐ฎ๐ฌ ๐€๐ฌ๐ข๐šโ€™๐ฌ ๐ง๐ž๐ฐ๐ฌ๐ฅ๐ž๐ญ๐ญ๐ž๐ซ! Stay informed with top ARTICLES, INTERVIEWS, INDUSTRIAL PROJECTS, TECHNO TREND reports, RESEARCH INSIGHTS, EVENTS, and more.

Elevate your knowledge to drive innovation in your organization. Donโ€™t forget to share with your network!

https://industry.pharmafocusasia.com/e-newsletters/1771483548-Feb-2026.html

๐’๐ฎ๐›๐ฌ๐œ๐ซ๐ข๐›๐ž ๐ง๐จ๐ฐ:
https://www.pharmafocusasia.com/e-newsletter-subscribe

๐‚๐ก๐ž๐ฆ๐ข๐œ๐š๐ฅ ๐ฌ๐œ๐ข๐ž๐ง๐œ๐ž๐ฌ ๐š๐ซ๐ž ๐ž๐ง๐ญ๐ž๐ซ๐ข๐ง๐  ๐š ๐ง๐ž๐ฐ ๐€๐ˆ-๐ฉ๐จ๐ฐ๐ž๐ซ๐ž๐ ๐ž๐ซ๐š.From computer-assisted molecular design to self-optimizing flow reac...
20/02/2026

๐‚๐ก๐ž๐ฆ๐ข๐œ๐š๐ฅ ๐ฌ๐œ๐ข๐ž๐ง๐œ๐ž๐ฌ ๐š๐ซ๐ž ๐ž๐ง๐ญ๐ž๐ซ๐ข๐ง๐  ๐š ๐ง๐ž๐ฐ ๐€๐ˆ-๐ฉ๐จ๐ฐ๐ž๐ซ๐ž๐ ๐ž๐ซ๐š.

From computer-assisted molecular design to self-optimizing flow reactors, AI/ML is transforming how drugs are designed, synthesized, and scaled safely.

In this thought-provoking piece by experts at the Institute of Chemical Technology, the message is clear: AI works best when guided by human insight.

Smarter synthesis planning.
Safer scale-up.
Greener chemistry.
Faster drug development.

๐‘๐ž๐š๐ ๐ญ๐ก๐ž ๐œ๐จ๐ฆ๐ฉ๐ฅ๐ž๐ญ๐ž ๐š๐ซ๐ญ๐ข๐œ๐ฅ๐ž ๐จ๐ง ๐จ๐ฎ๐ซ ๐ฐ๐ž๐›๐ฌ๐ข๐ญ๐ž and see how AI is shaping the next generation of pharmaceutical innovation: https://www.pharmafocusasia.com/articles/changing-paradigms-in-use-of-ai-in-chemical-sciences

๐‚๐จ๐ฅ๐จ๐ซ๐ž๐œ๐ญ๐š๐ฅ ๐œ๐š๐ง๐œ๐ž๐ซ continues to challenge global healthcare systems. Traditional chemotherapy often faces resistance and ...
19/02/2026

๐‚๐จ๐ฅ๐จ๐ซ๐ž๐œ๐ญ๐š๐ฅ ๐œ๐š๐ง๐œ๐ž๐ซ continues to challenge global healthcare systems. Traditional chemotherapy often faces resistance and systemic toxicityโ€”limiting patient outcomes.

Nano-based drug delivery systems are changing that.

๐‹๐ข๐ฉ๐ข๐ ๐ง๐š๐ง๐จ๐ฉ๐š๐ซ๐ญ๐ข๐œ๐ฅ๐ž๐ฌ ๐ก๐ž๐ฅ๐ฉ:
โ€ข Improve tumor-specific targeting
โ€ข Overcome multidrug resistance (P-gp related)
โ€ข Enhance drug loading & sustained release
โ€ข Reduce side effects on healthy cells

By leveraging lymphatic transport pathways and pH-sensitive coatings, nanomedicine is improving colorectal cancer management and therapeutic precision.

A smarter way forward in oncology treatment is taking shape.

๐‹๐ž๐š๐ซ๐ง ๐ฆ๐จ๐ซ๐ž ๐š๐ญ: https://www.pharmafocusasia.com/articles/nano-based-drug-delivery-system-for-hacking-colon-cancer-cells

Drug development costs are soaringโ€”yet many products fail before reaching the market.Bioscintigraphy, also known as ๐†๐š๐ฆ๐ฆ...
18/02/2026

Drug development costs are soaringโ€”yet many products fail before reaching the market.

Bioscintigraphy, also known as ๐†๐š๐ฆ๐ฆ๐š ๐’๐œ๐ข๐ง๐ญ๐ข๐ ๐ซ๐š๐ฉ๐ก๐ฒ, helps pharma teams visualize how a drug behaves inside the body in real time. From tracking GI transit of oral tablets to measuring lung deposition in inhalers and evaluating dermal patches, it supports smarter, evidence-based decisions.

Better data. Faster optimization. Stronger regulatory confidence.

๐‹๐ž๐š๐ซ๐ง ๐ฆ๐จ๐ซ๐ž: https://www.pharmafocusasia.com/articles/bioscintigraphy-an-innovative-tool-for-drug-product-development

If your label says 100 tablets, patients expect exactly 100โ€”and in perfect condition.But electronic counters and slat fi...
17/02/2026

If your label says 100 tablets, patients expect exactly 100โ€”and in perfect condition.

But electronic counters and slat fillers can face miscounts, broken products, and quality risks.

Thatโ€™s where ๐’๐๐ˆ๐๐„ ๐…๐ˆ๐๐Ž by ๐’๐ž๐ง๐ฌ๐ฎ๐ฆ makes a difference.

โœ… 100% visual inspection
โœ… Defect rejection before filling
โœ… Double counting system
โœ… No flaps = no post-count damage

One machine. Inspection, counting, and filling.

Smarter operations. Better product quality.

See how it worksโ€”visit our website today: https://www.pharmafocusasia.com/articles/electronic-counters-for-bottle-filling

๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ + ๐๐ซ๐ž๐œ๐ข๐ฌ๐ข๐จ๐ง = ๐“๐ก๐ž ๐…๐ฎ๐ญ๐ฎ๐ซ๐ž ๐จ๐Ÿ ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐จ๐ฏ๐ข๐ ๐ข๐ฅ๐š๐ง๐œ๐žBy Aarti Chitale, Principal โ€“ Healthcare & Life Sciences Growth ...
16/02/2026

๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ + ๐๐ซ๐ž๐œ๐ข๐ฌ๐ข๐จ๐ง = ๐“๐ก๐ž ๐…๐ฎ๐ญ๐ฎ๐ซ๐ž ๐จ๐Ÿ ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐จ๐ฏ๐ข๐ ๐ข๐ฅ๐š๐ง๐œ๐ž

By Aarti Chitale, Principal โ€“ Healthcare & Life Sciences Growth Opportunity Analytics, Frost & Sullivan

๐‡๐ž๐ซ๐žโ€™๐ฌ ๐ฐ๐ก๐š๐ญโ€™๐ฌ ๐ฌ๐ก๐š๐ฉ๐ข๐ง๐  ๐ญ๐ก๐ž ๐ง๐ž๐ฑ๐ญ ๐ž๐ซ๐š:
โœ” AI-powered adverse event reporting
โœ” Precision pharmacovigilance using genomics
โœ” Multi-vendor PV ecosystems
โœ” Cloud-based safety databases
โœ” Regulatory alignment across FDA, EMA & global bodies

With PV outsourcing expanding and safety services expected to cross $12B by 2030, pharma companies are investing in smarter, scalable systems that protect patients while accelerating innovation.

Patient-centric safety is becoming a competitive advantage.

๐‘๐ž๐š๐ ๐ญ๐ก๐ž ๐œ๐จ๐ฆ๐ฉ๐ฅ๐ž๐ญ๐ž ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐ง๐จ๐ฐ ๐จ๐ง ๐จ๐ฎ๐ซ ๐ฐ๐ž๐›๐ฌ๐ข๐ญ๐ž:
https://www.pharmafocusasia.com/articles/the-new-pharmacovigilance-era

Drug-resistant bacterial infections are becoming harder to treatโ€”and the pharma industry is actively seeking alternative...
13/02/2026

Drug-resistant bacterial infections are becoming harder to treatโ€”and the pharma industry is actively seeking alternatives.

๐‹๐ฎ๐ฆ๐ข๐ง๐ž๐ฌ๐œ๐ž๐ง๐ญ ๐œ๐š๐ซ๐›๐จ๐ง ๐๐จ๐ญ๐ฌ (๐‚-๐๐จ๐ญ๐ฌ) are showing promise as biocompatible nano-antibacterial agents. Their small size, surface charge tuning, and light-activated ROS generation enable them to target both Gram-positive and Gram-negative bacteria.

When paired with antibiotics like Ampicillin, C-dots demonstrate enhanced antibacterial effectsโ€”even against resistant strains, including Pseudomonas aeruginosa.

Nanotechnology is shaping the future of antimicrobial therapy.

๐‹๐ž๐š๐ซ๐ง ๐ฆ๐จ๐ซ๐ž ๐จ๐ง ๐จ๐ฎ๐ซ ๐ฐ๐ž๐›๐ฌ๐ข๐ญ๐ž:
https://www.pharmafocusasia.com/articles/luminescent-carbon-dots-an-emerging-nanomedicine-to-treat-antibiotic-resistant-bacterial-infections

Address

111, 112 First Floor, Block 2, White House
Hyderabad
500016

Website

Alerts

Be the first to know and let us send you an email when Pharma Focus Asia posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Pharma Focus Asia:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category